Högskolan i Skövde

his.sePublikasjoner
Endre søk
Begrens søket
1 - 7 of 7
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Treff pr side
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sortering
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
Merk
Maxantalet träffar du kan exportera från sökgränssnittet är 250. Vid större uttag använd dig av utsökningar.
  • 1.
    Delsing, Louise
    et al.
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningscentrum för Systembiologi. Department of Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden / Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Mölndal, Sweden.
    Kallur, Therese
    BioLamina, Sundbyberg, Sweden.
    Zetterberg, Henrik
    Department of Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden / Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden / Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK / UK Dementia Research Institute at UCL, London, UK.
    Hicks, Ryan
    Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Mölndal, Sweden.
    Synnergren, Jane
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningscentrum för Systembiologi.
    Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model2019Inngår i: Fluids and Barriers of the CNS, E-ISSN 2045-8118, Vol. 16, nr 1, artikkel-id 27Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background Human induced pluripotent stem cells (hiPSC) hold great promise for use in cell therapy applications and for improved in vitro models of human disease. So far, most hiPSC differentiation protocols to astroglia use undefined, animal-containing culture matrices. Laminins, which play an essential role in the regulation of cell behavior, offer a source of defined, animal-free culture matrix. Methods In order to understand how laminins affect astroglia differentiation, recombinant human laminin-521 (LN521), was compared to a murine Engelbreth-Holm-Swarm sarcoma derived laminin (L2020). Astroglia expression of protein and mRNA together with glutamate uptake and protein secretion function, were evaluated. Finally, these astroglia were evaluated in a coculture model of the blood-brain barrier (BBB). Results Astroglia of good quality were generated from hiPSC on both LN521 and L2020. However, astroglia differentiated on human LN521 showed higher expression of several astroglia specific mRNAs and proteins such as GFAP, S100B, Angiopoietin-1, and EAAT1, compared to astroglia differentiated on murine L2020. In addition, glutamate uptake and ability to induce expression of junction proteins in endothelial cells were affected by the culture matrix for differentiation. Conclusion Our results suggest that astroglia differentiated on LN521 display an improved phenotype and are suitable for coculture in a hiPSC-derived BBB model. This provides a starting point for a more defined and robust derivation of astroglia for use in BBB coculture models.

    Fulltekst (pdf)
    fulltext
  • 2.
    Kader, Rania
    et al.
    Högskolan i Skövde, Institutionen för hälsovetenskaper. Högskolan i Skövde, Forskningsmiljön hälsa, hållbarhet och digitalisering. Department of Women’s and Children’s Health, Uppsala University, Sweden ; Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Uppsala University, Sweden.
    Liminga, Gunnar
    Department of Women’s and Children’s Health, Uppsala University, Sweden.
    Ljungman, Gustaf
    Department of Women’s and Children’s Health, Uppsala University, Sweden.
    Paulsson, Mattias
    Department of Women’s and Children’s Health, Uppsala University, Sweden.
    Manipulations of Oral Medications in Paediatric Neurology and Oncology Care at a Swedish University Hospital: Health Professionals' Attitudes and Sources of Information2021Inngår i: Pharmaceutics, E-ISSN 1999-4923, Vol. 13, nr 10, artikkel-id 1676Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Oral administration of medications to children requires age-appropriate dosage forms and strengths. In this study, we: (i) assessed the extent of oral dosage form manipulations, (ii) documented how it is carried out, and (iii) examined the attitudes and sources of information regarding the handling from healthcare professionals. Prospective reviews of electronic records, ward observations, and clinician surveys were performed at a paediatric neurology ward and a paediatric oncology ward in Sweden during April to May of 2018. Approximately 15% of oral medications were manipulated for the studied patient group (median age 12.9 years in oncology, 5.8 years in neurology) with approximately 30% of the patients having an enteral feeding tube. Manipulations were performed both to obtain an appropriate dose from, for example, a fraction of the original tablet or to obtain a powder that could be used to prepare a slurry for administration through enteral feeding tubes. Risks identified were related to patient safety such as cross contamination, suboptimal absorption/pharmacokinetics and inaccurate dose. When examining the working environment of nurses, we observed safe handling of hazardous substances but the nurses occasionally experienced stress and a fear of making mistakes due to absence of information. Paediatricians experienced a lack of time to search for proper information on manipulations. As a step towards improving safety in paediatric medication, we suggest the introduction of clinical pharmacists into the team and further evaluating the possibilities of using more ready-to-administer medications with necessary product information and pharmacovigilance support.

    Fulltekst (pdf)
    fulltext
  • 3.
    Kantonen, Oskari
    et al.
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland ; Department of Perioperative Services, Intensive Care and Pain Medicine, Satakunta Central Hospital, Pori, Finland.
    Laaksonen, Lauri
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland.
    Alkire, Michael
    Department of Anesthesiology and Perioperative Medicine, University of California, Irvine, USA.
    Scheinin, Annalotta
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland.
    Långsjö, Jaakko
    Department of Intensive Care, Tampere University Hospital, Finland.
    Kallionpää, Roosa E.
    Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland ; Department of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Turun yliopisto, Finland.
    Kaisti, Kaike
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Anesthesiology and Intensive Care, Oulu University Hospital, Finland.
    Radek, Linda
    Turku PET Centre, University of Turku and Turku University Hospital, Finland.
    Johansson, Jarkko
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Radiation Sciences, Umeå University, Sweden.
    Laitio, Timo
    Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland.
    Maksimow, Anu
    Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland.
    Scheinin, Joonas
    Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland.
    Nyman, Mikko
    Department of Radiology, Turku University Hospital, Finland.
    Scheinin, Mika
    Institute of Biomedicine and Unit of Clinical Pharmacology, University of Turku and Turku University Hospital, Turun yliopisto, Finland.
    Solin, Olof
    Turku PET Centre, University of Turku and Turku University Hospital, Finland.
    Vahlberg, Tero
    Institute of Clinical Medicine, Biostatistics, University of Turku and Turku University Hospital, Turun yliopisto, Finland.
    Revonsuo, Antti
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningsmiljön Systembiologi. Department of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Turun yliopisto, Finland.
    Valli, Katja
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningsmiljön Systembiologi. Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland ; Department of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Turun yliopisto, Finland.
    Scheinin, Harry
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Perioperative Services, Intensive Care and Pain Medicine, Turku University Hospital, University of Turku, Finland ; Institute of Biomedicine and Unit of Clinical Pharmacology, University of Turku and Turku University Hospital, Turun yliopisto Finland.
    Decreased Thalamic Activity Is a Correlate for Disconnectedness during Anesthesia with Propofol, Dexmedetomidine and Sevoflurane But Not S-Ketamine2023Inngår i: Journal of Neuroscience, ISSN 0270-6474, E-ISSN 1529-2401, Vol. 43, nr 26, s. 4884-4895Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Establishing the neural mechanisms responsible for the altered global states of consciousness during anesthesia and dissociating these from other drug-related effects remains a challenge in consciousness research. We investigated differences in brain activity between connectedness and disconnectedness by administering various anesthetics at concentrations designed to render 50% of the subjects unresponsive. One hundred and sixty healthy male subjects were randomized to receive either propofol (1.7 μg/ml; n = 40), dexmedetomidine (1.5 ng/ml; n = 40), sevoflurane (0.9% end-tidal; n = 40), S-ketamine (0.75 μg/ml; n = 20), or saline placebo (n = 20) for 60 min using target-controlled infusions or vaporizer with end-tidal monitoring. Disconnectedness was defined as unresponsiveness to verbal commands probed at 2.5-min intervals and unawareness of external events in a postanesthesia interview. High-resolution positron emission tomography (PET) was used to quantify regional cerebral metabolic rates of glucose (CMRglu) utilization. Contrasting scans where the subjects were classified as connected and responsive versus disconnected and unresponsive revealed that for all anesthetics, except S-ketamine, the level of thalamic activity differed between these states. A conjunction analysis across the propofol, dexmedetomidine and sevoflurane groups confirmed the thalamus as the primary structure where reduced metabolic activity was related to disconnectedness. Widespread cortical metabolic suppression was observed when these subjects, classified as either connected or disconnected, were compared with the placebo group, suggesting that these findings may represent necessary but alone insufficient mechanisms for the change in the state of consciousness.

    Fulltekst (pdf)
    fulltext
  • 4.
    McBean, G. J.
    et al.
    School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.
    López, M. G.
    Instituto Teófilo Hernando for Drug Discovery, Department of Pharmacology, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
    Wallner, Fredrik K.
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningscentrum för Systembiologi. Redoxis AB.
    Redox-based therapeutics in neurodegenerative disease2017Inngår i: British Journal of Pharmacology, ISSN 0007-1188, E-ISSN 1476-5381, Vol. 174, nr 12, s. 1750-1770Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    This review describes recent developments in the search for effective therapeutic agents that target redox homeostasis in neurodegenerative disease. The disruption to thiol redox homeostasis in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis is discussed, together with the experimental strategies that are aimed at preventing, or at least minimizing, oxidative damage in these diseases. Particular attention is given to the potential of increasing antioxidant capacity by targeting the Nrf2 pathway, the development of inhibitors of NADPH oxidases that are likely candidates for clinical use, together with strategies to reduce nitrosative stress and mitochondrial dysfunction. We describe the shortcomings of compounds that hinder their progression to the clinic and evaluate likely avenues for future research.

  • 5.
    Nordh Jonsson, Malin
    et al.
    Högskolan i Skövde, Institutionen för kommunikation och information.
    Skog, Pia
    Högskolan i Skövde, Institutionen för kommunikation och information.
    Vad kan elever lära om ett ämne?: En fallstudie om de budskap som kan förmedlas genom lärarens och organisationens förhållningssätt2009Independent thesis Advanced level (professional degree), 10 poäng / 15 hpOppgave
    Abstract [en]

    As we have been actively involved in various teaching programmes for many years, we wanted to enquire how the students and teachers understood their school and compare it to how we experienced it.  Do the students fully understand the knowledge they are receiving and can they learn from it? Do the teachers believe what they are teaching is understood by the students? What is the underlining knowledge of social practices in the school, which can inspire students in different ways? The aim of the study, as the title suggests, is to convey and describe the various methods practiced in a specific social practice.

    Our project is a quality study.  We have used observation, specific intense individual and group interviews. In the result, arrives a different message through what there is possible for the students to learn about the matter. These messages are visible in the different attitudes the teacher, the school and the organisation have vis-à-vis the matter. In the discussion, we have focussed on what has arrived in the result around the teacher's and the organisation's attitudes. How can these attitudes influence the students' attitude to the matter and how will one work in order to become aware about the messages that are sent.

    Fulltekst (pdf)
    FULLTEXT02
  • 6.
    Nummela, Aleksi
    et al.
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Internal Medicine, Turku University Hospital, Finland.
    Laaksonen, Lauri
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Peri-operative Services, University of Turku and Turku University Hospital, Finland.
    Scheinin, Annalotta
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Peri-operative Services, University of Turku and Turku University Hospital, Finland.
    Kaisti, Kaike
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Peri-operative Services, University of Turku and Turku University Hospital, Finland.
    Vahlberg, Tero
    Department of Clinical Medicine, Biostatistics, Intensive Care and Pain Medicine, University of Turku and Turku University Hospital, Finland.
    Neuvonen, Mikko
    Department of Clinical Pharmacology, University of Helsinki, Finland ; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Finland.
    Valli, Katja
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningsmiljön Systembiologi. Department of Peri-operative Services, University of Turku and Turku University Hospital, Finland ; Department of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Finland.
    Revonsuo, Antti
    Högskolan i Skövde, Institutionen för biovetenskap. Högskolan i Skövde, Forskningsmiljön Systembiologi. Department of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Finland.
    Perola, Markus
    Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Finland ; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Finland ; Finnish Institute for Health and Welfare, Helsinki, Finland.
    Niemi, Mikko
    Department of Clinical Pharmacology, University of Helsinki, Finland ; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Finland ; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Finland.
    Scheinin, Harry
    Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Department of Peri-operative Services, University of Turku and Turku University Hospital, Finland ; Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Finland.
    Laitio, Timo
    Department of Peri-operative Services, University of Turku and Turku University Hospital, Finland.
    Circulating oxylipin and bile acid profiles of dexmedetomidine, propofol, sevoflurane, and S-ketamine: a randomised controlled trial using tandem mass spectrometry2022Inngår i: BJA Open, ISSN 2772-6096, Vol. 4, artikkel-id 100114Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background

    This exploratory study aimed to investigate whether dexmedetomidine, propofol, sevoflurane, and S-ketamine affect oxylipins and bile acids, which are functionally diverse molecules with possible connections to cellular bioenergetics, immune modulation, and organ protection.

    Methods

    In this randomised, open-label, controlled, parallel group, Phase IV clinical drug trial, healthy male subjects (n=160) received equipotent doses (EC50 for verbal command) of dexmedetomidine (1.5 ng ml−1; n=40), propofol (1.7 μg ml−1; n=40), sevoflurane (0.9% end-tidal; n=40), S-ketamine (0.75 μg ml−1; n=20), or placebo (n=20). Blood samples for tandem mass spectrometry were obtained at baseline, after study drug administration at 60 and 130 min from baseline; 40 metabolites were analysed.

    Results

    Statistically significant changes vs placebo were observed in 62.5%, 12.5%, 5.0%, and 2.5% of analytes in dexmedetomidine, propofol, sevoflurane, and S-ketamine groups, respectively. Data are presented as standard deviation score, 95% confidence interval, and P-value. Dexmedetomidine induced wide-ranging decreases in oxylipins and bile acids. Amongst others, 9,10-dihydroxyoctadecenoic acid (DiHOME) –1.19 (–1.6; –0.78), P<0.001 and 12,13-DiHOME –1.22 (–1.66; –0.77), P<0.001 were affected. Propofol elevated 9,10-DiHOME 2.29 (1.62; 2.96), P<0.001 and 12,13-DiHOME 2.13 (1.42; 2.84), P<0.001. Analytes were mostly unaffected by S-ketamine. Sevoflurane decreased tauroursodeoxycholic acid (TUDCA) –2.7 (–3.84; –1.55), P=0.015.

    Conclusions

    Dexmedetomidine-induced oxylipin alterations may be connected to pathways associated with organ protection. In contrast to dexmedetomidine, propofol emulsion elevated DiHOMEs, oxylipins associated with acute respiratory distress syndrome, and mitochondrial dysfunction in high concentrations. Further research is needed to establish the behaviour of DIHOMEs during prolonged propofol/dexmedetomidine infusions and to verify the sevoflurane-induced reduction in TUDCA, a suggested neuroprotective agent.

    Clinical trial registration

    NCT02624401.

    Fulltekst (pdf)
    fulltext
  • 7.
    Walladbegi, Java
    et al.
    Department of Oral Medicine & Pathology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
    Gellerstedt, Martin
    University West, School of Business, Economics and IT, University West, Trollhättan, Sweden.
    Svanberg, Anncarin
    Department of Hematology, Institute for Medical Sciences, Faculty of Medicine, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
    Jontell, Mats
    Department of Oral Medicine & Pathology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
    Innovative intraoral cooling device better tolerated and equally effective as ice cooling2017Inngår i: Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, E-ISSN 1432-0843, Vol. 80, nr 5, s. 965-972Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    PURPOSE: Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake and result in weight loss, a need for parenteral nutrition, and impaired quality of life. To date, there have been very few studies of evidence-based interventions for the prevention of OM. Cryotherapy, using ice chips, has been shown to reduce in an efficient manner the severity and extent of OM, although clinical applications are still limited due to several shortcomings, such as adverse tooth sensations, problems with infectious organisms in the water, nausea, and uneven cooling of the oral mucosa. The present proof-of-concept study was conducted to compare the tolerability, temperature reduction, and cooling distribution profiles of an intra-oral cooling device and ice chips in healthy volunteers who did not receive myeloablative treatment, and therefore, did not experience the symptoms of OM.

    METHODS: Twenty healthy volunteers used the cooling device and ice chips for a maximum of 60 min each, using a cross-over design. The baseline and final temperatures were measured at eight intra-oral locations using an infra-red thermographic camera. The thermographic images were analysed using two digital software packages. A questionnaire was used to assess the tolerability levels of the two interventions.

    RESULTS: The intra-oral cooling device was significantly better tolerated than the ice-chips (p = 0.0118). The two interventions were equally effective regarding temperature reduction and cooling distribution.

    CONCLUSIONS: The intra-oral cooling device shows superior tolerability in healthy volunteers. Furthermore, this study shows that temperature reduction and cooling distribution are achieved equally well using either method.

    Fulltekst (pdf)
    fulltext
1 - 7 of 7
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf